Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regulus Therapeutics Inc (NASDAQ:RGLS)

1.55
Delayed Data
As of Apr 28
 -0.05 / -3.13%
Today’s Change
0.94
Today|||52-Week Range
6.42
-31.11%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close1.60
Today’s open1.60
Day’s range1.50 - 1.65
Volume605,483
Average volume (3 months)1,029,370
Market cap$82.0M
Dividend yield--
Data as of 3:59pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)-43.52%
Earnings growth (this year)+9.03%
Earnings growth (next 5 years)--
Revenue growth (last year)-94.25%
P/E ratioNM
Price/Sales99.52
Price/Book1.46

Competitors

 Today’s
change
Today’s
% change
BLRXBioLine RX Ltd-0.01-0.86%
SNSSSunesis Pharmaceutic...+0.16+4.31%
IMMYImprimis Pharmaceuti...-0.24-5.57%
MNKDMannKind Corp-0.00-0.39%
Data as of 4:00pm ET, 04/28/2017

Financials

Next reporting dateMay 5, 2017
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$1.2M
Annual profit (last year)-$81.8M
Net profit margin-6,853.94%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Paul C. Grint
COO, Chief Financial &
Accounting Officer
Joseph P. Hagan
Corporate headquarters
San Diego, California

Forecasts